Carolinas Wealth Consulting LLC Eli Lilly & CO Transaction History

Carolinas Wealth Consulting LLC

$577 Million
Q3 2024

A detailed history of Carolinas Wealth Consulting LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 268 shares of LLY stock, worth $205,448. This represents 0.04% of its overall portfolio holdings.

Number of Shares

268

Previous 320 16.25%

Holding current value

$205,448

Previous $289,000 17.99%

% of portfolio

0.04%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $40,151 - $49,921	-52 Reduced 16.25%	268 $237,000
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $28,994 - $36,361	40 Added 14.29%	320 $289,000
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $24.3 Million - $32.5 Million	-40,996 Reduced 99.32%	280 $217,000
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $13,654 - $16,097	26 Added 0.06%	41,276 $24.1 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $111,717 - $154,020	-257 Reduced 0.62%	41,250 $22.2 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $64,886 - $86,761	-185 Reduced 0.44%	41,507 $19.5 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $4,038 - $4,742	13 Added 0.03%	41,692 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $321 - $374	1 Added 0.0%	41,679 $15.2 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $53,069 - $60,478	-179 Reduced 0.43%	41,678 $293,000
Q2 2022 Aug 16, 2022	BUY	$278.73 - $327.27 $11.5 Million - $13.5 Million	41,198 Added 6251.59%	41,857 $352,000
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $938 - $1,166	-4 Reduced 0.6%	659 $189,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $36,425 - $45,204	-162 Reduced 19.64%	663 $183,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $31,245 - $38,452	141 Added 20.61%	825 $191,000
Q2 2021 Aug 17, 2021	BUY	$180.55 - $233.54 $20,041 - $25,922	111 Added 19.37%	684 $157,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $46,666 - $60,412	-284 Reduced 33.14%	573 $107,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $2,348 - $3,107	18 Added 2.15%	857 $145,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $95,335 - $110,272	652 Added 348.66%	839 $124,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $25,510 - $30,701	187 New	187 $31,000

Others Institutions Holding LLY

# of Institutions

4,031

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.

Account

Carolinas Wealth Consulting LLC Eli Lilly & CO Transaction History